Reaching Out to Caregivers of Veterans With Dementia

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Reaching Out to Caregivers of Veterans With Dementia

Article PDF
Author and Disclosure Information

Candice M. Daniel, PhD; Robert D. Hill, PhD, ABPP; Marilyn Luptak, PhD, MSW; Bret L. Hicken, PhD, MSPH; Robert Zheng, PhD; Christopher M. Turner; and Randall Rupper, MD

Dr. Daniel is a VA special fellow in advanced geriatrics with the VA Salt Lake City Health Care System (VASLCHCS) Geriatric Research Education and Clinical Center (GRECC) in Utah. Dr. Luptak is an assistant professor in the College of Social Work, and Drs. Hill and Zheng are professors in the department of educational psychology, all at the University of Utah in Salt Lake City. Dr. Hicken is a research scientist, and Mr. Turner is a program specialist, both at the VA Office for Rural health in Salt Lake City. Dr. Rupper is a phyisican investiagor with the VASLCHCS GRECC.

Issue
Federal Practitioner - 28(11)
Publications
Topics
Page Number
43
Legacy Keywords
dementia, Geriatric Research Education and Clinical Centers, GRECCs, VA Salt Lake City Health Care Systemdementia, Geriatric Research Education and Clinical Centers, GRECCs, VA Salt Lake City Health Care System
Sections
Author and Disclosure Information

Candice M. Daniel, PhD; Robert D. Hill, PhD, ABPP; Marilyn Luptak, PhD, MSW; Bret L. Hicken, PhD, MSPH; Robert Zheng, PhD; Christopher M. Turner; and Randall Rupper, MD

Dr. Daniel is a VA special fellow in advanced geriatrics with the VA Salt Lake City Health Care System (VASLCHCS) Geriatric Research Education and Clinical Center (GRECC) in Utah. Dr. Luptak is an assistant professor in the College of Social Work, and Drs. Hill and Zheng are professors in the department of educational psychology, all at the University of Utah in Salt Lake City. Dr. Hicken is a research scientist, and Mr. Turner is a program specialist, both at the VA Office for Rural health in Salt Lake City. Dr. Rupper is a phyisican investiagor with the VASLCHCS GRECC.

Author and Disclosure Information

Candice M. Daniel, PhD; Robert D. Hill, PhD, ABPP; Marilyn Luptak, PhD, MSW; Bret L. Hicken, PhD, MSPH; Robert Zheng, PhD; Christopher M. Turner; and Randall Rupper, MD

Dr. Daniel is a VA special fellow in advanced geriatrics with the VA Salt Lake City Health Care System (VASLCHCS) Geriatric Research Education and Clinical Center (GRECC) in Utah. Dr. Luptak is an assistant professor in the College of Social Work, and Drs. Hill and Zheng are professors in the department of educational psychology, all at the University of Utah in Salt Lake City. Dr. Hicken is a research scientist, and Mr. Turner is a program specialist, both at the VA Office for Rural health in Salt Lake City. Dr. Rupper is a phyisican investiagor with the VASLCHCS GRECC.

Article PDF
Article PDF

Issue
Federal Practitioner - 28(11)
Issue
Federal Practitioner - 28(11)
Page Number
43
Page Number
43
Publications
Publications
Topics
Article Type
Display Headline
Reaching Out to Caregivers of Veterans With Dementia
Display Headline
Reaching Out to Caregivers of Veterans With Dementia
Legacy Keywords
dementia, Geriatric Research Education and Clinical Centers, GRECCs, VA Salt Lake City Health Care Systemdementia, Geriatric Research Education and Clinical Centers, GRECCs, VA Salt Lake City Health Care System
Legacy Keywords
dementia, Geriatric Research Education and Clinical Centers, GRECCs, VA Salt Lake City Health Care Systemdementia, Geriatric Research Education and Clinical Centers, GRECCs, VA Salt Lake City Health Care System
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Dietary Sodium Restriction in Veterans: A Modifiable Risk Factor for Chronic Disease

Article Type
Changed
Tue, 05/03/2022 - 15:59
Display Headline
Dietary Sodium Restriction in Veterans: A Modifiable Risk Factor for Chronic Disease

Article PDF
Author and Disclosure Information

Venkata Yalamanchili, MD; Jill Struble, RD, LDN; Lynn A. Novorska, RD, LDN; Robert F. Reilly, MD

Dr. Yalamanchili is a fellow in the section of nephrology and Dr. Reilly is an assistant chief, medical service, both at the VA North Texas Health Care System in Dallas. Ms. Struble is a clinical dietician at the Pitssburgh VA Medical Center in Pennsylvania. Ms. Novorska is the MOVE! Dietician Program Coordinator at the VHA National Center for Health Promotion and Disease Prevention in Durham, North Carolina. Dr. Reilly is also the Fredric L. Coe Professor of Nephrolithiasis Research and Dr. Yalamanchili is a renal fellow, both at the University of Texas Southwestern Medical Center in Dallas.

Issue
Federal Practitioner - 28(10)
Publications
Topics
Page Number
39
Legacy Keywords
MOVE! program, tobacco cessation, weight management, INTERSALT, Venkata Yalamanchili, MD, Jill Struble, RD, LDN, Lynn A. Novorska, RD, LDN, Robert F. Reilly, MD, Margaret Cary, MDMOVE! program, tobacco cessation, weight management, INTERSALT, Venkata Yalamanchili, MD, Jill Struble, RD, LDN, Lynn A. Novorska, RD, LDN, Robert F. Reilly, MD, Margaret Cary, MD
Sections
Author and Disclosure Information

Venkata Yalamanchili, MD; Jill Struble, RD, LDN; Lynn A. Novorska, RD, LDN; Robert F. Reilly, MD

Dr. Yalamanchili is a fellow in the section of nephrology and Dr. Reilly is an assistant chief, medical service, both at the VA North Texas Health Care System in Dallas. Ms. Struble is a clinical dietician at the Pitssburgh VA Medical Center in Pennsylvania. Ms. Novorska is the MOVE! Dietician Program Coordinator at the VHA National Center for Health Promotion and Disease Prevention in Durham, North Carolina. Dr. Reilly is also the Fredric L. Coe Professor of Nephrolithiasis Research and Dr. Yalamanchili is a renal fellow, both at the University of Texas Southwestern Medical Center in Dallas.

Author and Disclosure Information

Venkata Yalamanchili, MD; Jill Struble, RD, LDN; Lynn A. Novorska, RD, LDN; Robert F. Reilly, MD

Dr. Yalamanchili is a fellow in the section of nephrology and Dr. Reilly is an assistant chief, medical service, both at the VA North Texas Health Care System in Dallas. Ms. Struble is a clinical dietician at the Pitssburgh VA Medical Center in Pennsylvania. Ms. Novorska is the MOVE! Dietician Program Coordinator at the VHA National Center for Health Promotion and Disease Prevention in Durham, North Carolina. Dr. Reilly is also the Fredric L. Coe Professor of Nephrolithiasis Research and Dr. Yalamanchili is a renal fellow, both at the University of Texas Southwestern Medical Center in Dallas.

Article PDF
Article PDF

Issue
Federal Practitioner - 28(10)
Issue
Federal Practitioner - 28(10)
Page Number
39
Page Number
39
Publications
Publications
Topics
Article Type
Display Headline
Dietary Sodium Restriction in Veterans: A Modifiable Risk Factor for Chronic Disease
Display Headline
Dietary Sodium Restriction in Veterans: A Modifiable Risk Factor for Chronic Disease
Legacy Keywords
MOVE! program, tobacco cessation, weight management, INTERSALT, Venkata Yalamanchili, MD, Jill Struble, RD, LDN, Lynn A. Novorska, RD, LDN, Robert F. Reilly, MD, Margaret Cary, MDMOVE! program, tobacco cessation, weight management, INTERSALT, Venkata Yalamanchili, MD, Jill Struble, RD, LDN, Lynn A. Novorska, RD, LDN, Robert F. Reilly, MD, Margaret Cary, MD
Legacy Keywords
MOVE! program, tobacco cessation, weight management, INTERSALT, Venkata Yalamanchili, MD, Jill Struble, RD, LDN, Lynn A. Novorska, RD, LDN, Robert F. Reilly, MD, Margaret Cary, MDMOVE! program, tobacco cessation, weight management, INTERSALT, Venkata Yalamanchili, MD, Jill Struble, RD, LDN, Lynn A. Novorska, RD, LDN, Robert F. Reilly, MD, Margaret Cary, MD
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

BEST PRACTICES IN: Managing Eczema With Natural Ingredients

Article Type
Changed
Thu, 12/06/2018 - 16:18
Display Headline
BEST PRACTICES IN: Managing Eczema With Natural Ingredients

A supplement to Pediatric News.
This supplement was sponsored by Johnson & Johnson Consumer Products Company


Topics

• What Role Should Colloidal Oatmeal Play?
• What Other Naturally Derived Ingredients May Benefit Patients With AD?
• The Value of 510(k) Products in Eczema

Faculty/Faculty Disclosure

Lawrence Eichenfield, MD
Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital and the University of California
San Diego School of Medicine
Professor of Clinical Pediatrics and Medicine (Dermatology)
The University of California
San Diego, CA


Dr Eichenfield was a consultant to Johnson and Johnson.


Melissa Reyes Merin, MD
Clinical Fellow
Rady Children's Hospital
San Diego, CA


Dr Reyes Merin has nothing to disclose.

 

To view the supplement, click the image above.

Article PDF
Author and Disclosure Information

 

 

Publications
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

Article PDF
Article PDF

A supplement to Pediatric News.
This supplement was sponsored by Johnson & Johnson Consumer Products Company


Topics

• What Role Should Colloidal Oatmeal Play?
• What Other Naturally Derived Ingredients May Benefit Patients With AD?
• The Value of 510(k) Products in Eczema

Faculty/Faculty Disclosure

Lawrence Eichenfield, MD
Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital and the University of California
San Diego School of Medicine
Professor of Clinical Pediatrics and Medicine (Dermatology)
The University of California
San Diego, CA


Dr Eichenfield was a consultant to Johnson and Johnson.


Melissa Reyes Merin, MD
Clinical Fellow
Rady Children's Hospital
San Diego, CA


Dr Reyes Merin has nothing to disclose.

 

To view the supplement, click the image above.

A supplement to Pediatric News.
This supplement was sponsored by Johnson & Johnson Consumer Products Company


Topics

• What Role Should Colloidal Oatmeal Play?
• What Other Naturally Derived Ingredients May Benefit Patients With AD?
• The Value of 510(k) Products in Eczema

Faculty/Faculty Disclosure

Lawrence Eichenfield, MD
Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital and the University of California
San Diego School of Medicine
Professor of Clinical Pediatrics and Medicine (Dermatology)
The University of California
San Diego, CA


Dr Eichenfield was a consultant to Johnson and Johnson.


Melissa Reyes Merin, MD
Clinical Fellow
Rady Children's Hospital
San Diego, CA


Dr Reyes Merin has nothing to disclose.

 

To view the supplement, click the image above.

Publications
Publications
Article Type
Display Headline
BEST PRACTICES IN: Managing Eczema With Natural Ingredients
Display Headline
BEST PRACTICES IN: Managing Eczema With Natural Ingredients
Sections
Disallow All Ads
Article PDF Media

BEST PRACTICES IN: The Role of Copay Reduction Programs Within a Physician's Practice.

Article Type
Changed
Thu, 12/06/2018 - 16:09
Display Headline
BEST PRACTICES IN: The Role of Copay Reduction Programs Within a Physician's Practice.

 

A supplement to Pediatric News.
This supplement was sponsored by Ferndale Laboratories Inc.



Topics Highlights

• Copay Reduction
• Patient Rebate Programs
• Prescription Abandonment Rates
• Importance of Communication between Providers and their Patients

Faculty/Faculty Disclosure

Joseph S. Eastern, MD
Clinical Associate Professor of Dermatology
Seton Hall University
School of Graduate
Medical Education
South Orange, NJ


Dr Eastern has a consulting agreement with Abbott Laboratories, Amgen, Inc., Aqua Pharmaceuticals, LLC, Graceway Pharmaceuticals, LLC, Medicis Pharmaceutical Corporation, Promius Pharma, LLC, Stiefel Laboratories, Inc., Quinnova Pharmaceuticals, Inc., and Warner Chilcott; and is a stockholder of Medicis.


Copyright © 2010 Elsevier Inc.

 

To view the supplement, click the image above.
 

Article PDF
Author and Disclosure Information

 

 

Publications
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

Article PDF
Article PDF

 

A supplement to Pediatric News.
This supplement was sponsored by Ferndale Laboratories Inc.



Topics Highlights

• Copay Reduction
• Patient Rebate Programs
• Prescription Abandonment Rates
• Importance of Communication between Providers and their Patients

Faculty/Faculty Disclosure

Joseph S. Eastern, MD
Clinical Associate Professor of Dermatology
Seton Hall University
School of Graduate
Medical Education
South Orange, NJ


Dr Eastern has a consulting agreement with Abbott Laboratories, Amgen, Inc., Aqua Pharmaceuticals, LLC, Graceway Pharmaceuticals, LLC, Medicis Pharmaceutical Corporation, Promius Pharma, LLC, Stiefel Laboratories, Inc., Quinnova Pharmaceuticals, Inc., and Warner Chilcott; and is a stockholder of Medicis.


Copyright © 2010 Elsevier Inc.

 

To view the supplement, click the image above.
 

 

A supplement to Pediatric News.
This supplement was sponsored by Ferndale Laboratories Inc.



Topics Highlights

• Copay Reduction
• Patient Rebate Programs
• Prescription Abandonment Rates
• Importance of Communication between Providers and their Patients

Faculty/Faculty Disclosure

Joseph S. Eastern, MD
Clinical Associate Professor of Dermatology
Seton Hall University
School of Graduate
Medical Education
South Orange, NJ


Dr Eastern has a consulting agreement with Abbott Laboratories, Amgen, Inc., Aqua Pharmaceuticals, LLC, Graceway Pharmaceuticals, LLC, Medicis Pharmaceutical Corporation, Promius Pharma, LLC, Stiefel Laboratories, Inc., Quinnova Pharmaceuticals, Inc., and Warner Chilcott; and is a stockholder of Medicis.


Copyright © 2010 Elsevier Inc.

 

To view the supplement, click the image above.
 

Publications
Publications
Article Type
Display Headline
BEST PRACTICES IN: The Role of Copay Reduction Programs Within a Physician's Practice.
Display Headline
BEST PRACTICES IN: The Role of Copay Reduction Programs Within a Physician's Practice.
Sections
Disallow All Ads
Article PDF Media

BEST PRACTICES IN: Newer Topical Retinoid Therapies for the Treatment of Acne

Article Type
Changed
Thu, 12/06/2018 - 16:09
Display Headline
BEST PRACTICES IN: Newer Topical Retinoid Therapies for the Treatment of Acne

 

A supplement to Pediatric News and funded by Galderma.



TOPICS

• Current Thinking Around Acne Therapy
• Topical Retinoids: The Cornerstone of Therapy
• Evolution of Topical Retinoids
• Tolerability of Topical Retinoids
• Summary

FACULTY

Lawrence F. Eichenfield, MD
Chief, Pediatric and Adolescent Dermatology
Professor of Pediatrics and Medicine (Dermatology)
Rady Children's Hospital, San Diego
University of California, San Diego School of Medicine


Diane M. Thiboutot, MD
Professor and Vice Chair of Dermatology Research
Co-Director, MD/PhD Program
Associate Program Director, GCRC
Penn State University College of Medicine
Hershey, Pennsylvania


Copyright © 2008 Elsevier Inc.

 

To view the supplement, click the image above.

Article PDF
Author and Disclosure Information

 

 

Publications
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

Article PDF
Article PDF

 

A supplement to Pediatric News and funded by Galderma.



TOPICS

• Current Thinking Around Acne Therapy
• Topical Retinoids: The Cornerstone of Therapy
• Evolution of Topical Retinoids
• Tolerability of Topical Retinoids
• Summary

FACULTY

Lawrence F. Eichenfield, MD
Chief, Pediatric and Adolescent Dermatology
Professor of Pediatrics and Medicine (Dermatology)
Rady Children's Hospital, San Diego
University of California, San Diego School of Medicine


Diane M. Thiboutot, MD
Professor and Vice Chair of Dermatology Research
Co-Director, MD/PhD Program
Associate Program Director, GCRC
Penn State University College of Medicine
Hershey, Pennsylvania


Copyright © 2008 Elsevier Inc.

 

To view the supplement, click the image above.

 

A supplement to Pediatric News and funded by Galderma.



TOPICS

• Current Thinking Around Acne Therapy
• Topical Retinoids: The Cornerstone of Therapy
• Evolution of Topical Retinoids
• Tolerability of Topical Retinoids
• Summary

FACULTY

Lawrence F. Eichenfield, MD
Chief, Pediatric and Adolescent Dermatology
Professor of Pediatrics and Medicine (Dermatology)
Rady Children's Hospital, San Diego
University of California, San Diego School of Medicine


Diane M. Thiboutot, MD
Professor and Vice Chair of Dermatology Research
Co-Director, MD/PhD Program
Associate Program Director, GCRC
Penn State University College of Medicine
Hershey, Pennsylvania


Copyright © 2008 Elsevier Inc.

 

To view the supplement, click the image above.

Publications
Publications
Article Type
Display Headline
BEST PRACTICES IN: Newer Topical Retinoid Therapies for the Treatment of Acne
Display Headline
BEST PRACTICES IN: Newer Topical Retinoid Therapies for the Treatment of Acne
Sections
Disallow All Ads
Article PDF Media

The VHA's National Pain Management Strategy: Implementing the Stepped Care Model

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
The VHA's National Pain Management Strategy: Implementing the Stepped Care Model
Updates in Specialty Care

Article PDF
Author and Disclosure Information

Patricia H. Rosenberger, PhD; Errol J. Philip, PhD; Allison Lee, BA; and Robert D. Kerns, PhD.

Dr. Rosenberger is a research psychologist at the VA Connecticut Healthcare System in West Haven and assistant professor at Yale University School of Medicine in New Haven, Connecticut. Dr. Philip is a postdoctoral fellow at Memorial Sloan Kettering Cancer Center in New York, and Ms. Lee is a research assistant at Yale University School of Medicine. Dr. Kerns is the national program director for pain management at the VA Central Office in West Haven, Connecticut; the director of the Pain Research, Information, Medical Comorbodities, and Education (PRIME) Center at the VA Connecticut Healthcare System; and a professor at Yalue University School of Medicine.

Issue
Federal Practitioner - 28(8)
Publications
Topics
Page Number
39
Legacy Keywords
pain, chronic pain, emotional distress, substance abuse, economic costs, VHA National Pain Management Strategy, VHA, Stepped Care Model for Pain Management, SCM-PM, pain management, Commission for the Accreditation of Rehabilitation Facilities, CARDpain, chronic pain, emotional distress, substance abuse, economic costs, VHA National Pain Management Strategy, VHA, Stepped Care Model for Pain Management, SCM-PM, pain management, Commission for the Accreditation of Rehabilitation Facilities, CARD
Sections
Author and Disclosure Information

Patricia H. Rosenberger, PhD; Errol J. Philip, PhD; Allison Lee, BA; and Robert D. Kerns, PhD.

Dr. Rosenberger is a research psychologist at the VA Connecticut Healthcare System in West Haven and assistant professor at Yale University School of Medicine in New Haven, Connecticut. Dr. Philip is a postdoctoral fellow at Memorial Sloan Kettering Cancer Center in New York, and Ms. Lee is a research assistant at Yale University School of Medicine. Dr. Kerns is the national program director for pain management at the VA Central Office in West Haven, Connecticut; the director of the Pain Research, Information, Medical Comorbodities, and Education (PRIME) Center at the VA Connecticut Healthcare System; and a professor at Yalue University School of Medicine.

Author and Disclosure Information

Patricia H. Rosenberger, PhD; Errol J. Philip, PhD; Allison Lee, BA; and Robert D. Kerns, PhD.

Dr. Rosenberger is a research psychologist at the VA Connecticut Healthcare System in West Haven and assistant professor at Yale University School of Medicine in New Haven, Connecticut. Dr. Philip is a postdoctoral fellow at Memorial Sloan Kettering Cancer Center in New York, and Ms. Lee is a research assistant at Yale University School of Medicine. Dr. Kerns is the national program director for pain management at the VA Central Office in West Haven, Connecticut; the director of the Pain Research, Information, Medical Comorbodities, and Education (PRIME) Center at the VA Connecticut Healthcare System; and a professor at Yalue University School of Medicine.

Article PDF
Article PDF
Updates in Specialty Care
Updates in Specialty Care

Issue
Federal Practitioner - 28(8)
Issue
Federal Practitioner - 28(8)
Page Number
39
Page Number
39
Publications
Publications
Topics
Article Type
Display Headline
The VHA's National Pain Management Strategy: Implementing the Stepped Care Model
Display Headline
The VHA's National Pain Management Strategy: Implementing the Stepped Care Model
Legacy Keywords
pain, chronic pain, emotional distress, substance abuse, economic costs, VHA National Pain Management Strategy, VHA, Stepped Care Model for Pain Management, SCM-PM, pain management, Commission for the Accreditation of Rehabilitation Facilities, CARDpain, chronic pain, emotional distress, substance abuse, economic costs, VHA National Pain Management Strategy, VHA, Stepped Care Model for Pain Management, SCM-PM, pain management, Commission for the Accreditation of Rehabilitation Facilities, CARD
Legacy Keywords
pain, chronic pain, emotional distress, substance abuse, economic costs, VHA National Pain Management Strategy, VHA, Stepped Care Model for Pain Management, SCM-PM, pain management, Commission for the Accreditation of Rehabilitation Facilities, CARDpain, chronic pain, emotional distress, substance abuse, economic costs, VHA National Pain Management Strategy, VHA, Stepped Care Model for Pain Management, SCM-PM, pain management, Commission for the Accreditation of Rehabilitation Facilities, CARD
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Management of Patients With Amyotrophic Lateral Sclerosis

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Management of Patients With Amyotrophic Lateral Sclerosis

Article PDF
Author and Disclosure Information

Patricia G. Banks, RN, MSNEd, CCRP; and Robert L. Ruff, MD, Phd

Ms. Banks is a program coordinator and analyst, and Dr. Ruff is the national chief of neurology services, both at the Louis Stoke Cleveland VA Medical Center in Ohio.

Issue
Federal Practitioner - 28(6)
Publications
Topics
Page Number
32
Legacy Keywords
amyotrophic lateral sclerosis, ALS, neurodegenerative disease, motor control neurons, spinal cord, brain stem, motor cortex, muscle weakness, atrophy, corticospinal tract signs, hyperactive tendon reflexes, clonus, spasticity, positive Babinsky sign, death, respiratory failure, bulbar musculature, lower-extremity spasms, cramps, Sporadic ALS, Familial ALS, FALS, Institute of Medicine, IOM, neurologic examination, electrodiagnostic tests, electromyography, nerve conduction velocity, anti-GM1 antibody syndrome, assistive technology, AT, prosthetic and sensory aids services, PSAS, VA Health Care System, VAHCSamyotrophic lateral sclerosis, ALS, neurodegenerative disease, motor control neurons, spinal cord, brain stem, motor cortex, muscle weakness, atrophy, corticospinal tract signs, hyperactive tendon reflexes, clonus, spasticity, positive Babinsky sign, death, respiratory failure, bulbar musculature, lower-extremity spasms, cramps, Sporadic ALS, Familial ALS, FALS, Institute of Medicine, IOM, neurologic examination, electrodiagnostic tests, electromyography, nerve conduction velocity, anti-GM1 antibody syndrome, assistive technology, AT, prosthetic and sensory aids services, PSAS, VA Health Care System, VAHCS
Sections
Author and Disclosure Information

Patricia G. Banks, RN, MSNEd, CCRP; and Robert L. Ruff, MD, Phd

Ms. Banks is a program coordinator and analyst, and Dr. Ruff is the national chief of neurology services, both at the Louis Stoke Cleveland VA Medical Center in Ohio.

Author and Disclosure Information

Patricia G. Banks, RN, MSNEd, CCRP; and Robert L. Ruff, MD, Phd

Ms. Banks is a program coordinator and analyst, and Dr. Ruff is the national chief of neurology services, both at the Louis Stoke Cleveland VA Medical Center in Ohio.

Article PDF
Article PDF

Issue
Federal Practitioner - 28(6)
Issue
Federal Practitioner - 28(6)
Page Number
32
Page Number
32
Publications
Publications
Topics
Article Type
Display Headline
Management of Patients With Amyotrophic Lateral Sclerosis
Display Headline
Management of Patients With Amyotrophic Lateral Sclerosis
Legacy Keywords
amyotrophic lateral sclerosis, ALS, neurodegenerative disease, motor control neurons, spinal cord, brain stem, motor cortex, muscle weakness, atrophy, corticospinal tract signs, hyperactive tendon reflexes, clonus, spasticity, positive Babinsky sign, death, respiratory failure, bulbar musculature, lower-extremity spasms, cramps, Sporadic ALS, Familial ALS, FALS, Institute of Medicine, IOM, neurologic examination, electrodiagnostic tests, electromyography, nerve conduction velocity, anti-GM1 antibody syndrome, assistive technology, AT, prosthetic and sensory aids services, PSAS, VA Health Care System, VAHCSamyotrophic lateral sclerosis, ALS, neurodegenerative disease, motor control neurons, spinal cord, brain stem, motor cortex, muscle weakness, atrophy, corticospinal tract signs, hyperactive tendon reflexes, clonus, spasticity, positive Babinsky sign, death, respiratory failure, bulbar musculature, lower-extremity spasms, cramps, Sporadic ALS, Familial ALS, FALS, Institute of Medicine, IOM, neurologic examination, electrodiagnostic tests, electromyography, nerve conduction velocity, anti-GM1 antibody syndrome, assistive technology, AT, prosthetic and sensory aids services, PSAS, VA Health Care System, VAHCS
Legacy Keywords
amyotrophic lateral sclerosis, ALS, neurodegenerative disease, motor control neurons, spinal cord, brain stem, motor cortex, muscle weakness, atrophy, corticospinal tract signs, hyperactive tendon reflexes, clonus, spasticity, positive Babinsky sign, death, respiratory failure, bulbar musculature, lower-extremity spasms, cramps, Sporadic ALS, Familial ALS, FALS, Institute of Medicine, IOM, neurologic examination, electrodiagnostic tests, electromyography, nerve conduction velocity, anti-GM1 antibody syndrome, assistive technology, AT, prosthetic and sensory aids services, PSAS, VA Health Care System, VAHCSamyotrophic lateral sclerosis, ALS, neurodegenerative disease, motor control neurons, spinal cord, brain stem, motor cortex, muscle weakness, atrophy, corticospinal tract signs, hyperactive tendon reflexes, clonus, spasticity, positive Babinsky sign, death, respiratory failure, bulbar musculature, lower-extremity spasms, cramps, Sporadic ALS, Familial ALS, FALS, Institute of Medicine, IOM, neurologic examination, electrodiagnostic tests, electromyography, nerve conduction velocity, anti-GM1 antibody syndrome, assistive technology, AT, prosthetic and sensory aids services, PSAS, VA Health Care System, VAHCS
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Updates in Specialty Care

Article Type
Changed
Tue, 05/03/2022 - 16:00
Display Headline
Updates in Specialty Care

Article PDF
Author and Disclosure Information

Leonard Pogach, MD, MBA; Paul R. Conlin, MD; Curtis Hobbs, MD; Robert A. Vigersky, MD; and David Aron, MD, MS; for the VA-DoD Diabetes Guideline Working Group

Dr. Pogach is director, Health Services Research & Development (HSR&D) Center for Healthcare Knowledge Management at the VA New Jersey Health Care System in East Orange and national program director, Endocrinology and Diabetes, Office of Subspecialty Services in the VA Office of Patient Care Services in Washington, DC. Dr. Conlin is chief of medicine at the VA Boston Healthcare System in Massachusetts. Dr. Hobbs is director, Diabetes Care Center, Madigan Healthcare System at Madigan Army Medical Center in Tacoma, Washington. Dr. Vigersky is director, Diabetes Institute, Walter Reed Health Care System at Walter Reed Army Medical Center in Washington, DC. Dr. Aron is associate chief of staff/education and co-director, VA HSR&D Center for Implementation Practice and Research Support at Louis Stokes Cleveland VA Medical Center in Ohio.

Issue
Federal Practitioner - 28(4)
Publications
Topics
Page Number
39
Legacy Keywords
diabetes, clinical practice guidelines, GRADE instrument, comorbid conditions, glycemic targets, A1c tests, estimated average glucose, glucose-based tests, glycemic control, hemolytic anemia, iron deficiency anemia, severe chronic kidney disease, National Glycohemoglobin Standardization Program, coefficient of variation, mean plasma glucose, Working Group, glucose-lowering agents, Action to Control Cardiovascular Risk in Diabetes, VA Diabetes Trial, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluationdiabetes, clinical practice guidelines, GRADE instrument, comorbid conditions, glycemic targets, A1c tests, estimated average glucose, glucose-based tests, glycemic control, hemolytic anemia, iron deficiency anemia, severe chronic kidney disease, National Glycohemoglobin Standardization Program, coefficient of variation, mean plasma glucose, Working Group, glucose-lowering agents, Action to Control Cardiovascular Risk in Diabetes, VA Diabetes Trial, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation
Sections
Author and Disclosure Information

Leonard Pogach, MD, MBA; Paul R. Conlin, MD; Curtis Hobbs, MD; Robert A. Vigersky, MD; and David Aron, MD, MS; for the VA-DoD Diabetes Guideline Working Group

Dr. Pogach is director, Health Services Research & Development (HSR&D) Center for Healthcare Knowledge Management at the VA New Jersey Health Care System in East Orange and national program director, Endocrinology and Diabetes, Office of Subspecialty Services in the VA Office of Patient Care Services in Washington, DC. Dr. Conlin is chief of medicine at the VA Boston Healthcare System in Massachusetts. Dr. Hobbs is director, Diabetes Care Center, Madigan Healthcare System at Madigan Army Medical Center in Tacoma, Washington. Dr. Vigersky is director, Diabetes Institute, Walter Reed Health Care System at Walter Reed Army Medical Center in Washington, DC. Dr. Aron is associate chief of staff/education and co-director, VA HSR&D Center for Implementation Practice and Research Support at Louis Stokes Cleveland VA Medical Center in Ohio.

Author and Disclosure Information

Leonard Pogach, MD, MBA; Paul R. Conlin, MD; Curtis Hobbs, MD; Robert A. Vigersky, MD; and David Aron, MD, MS; for the VA-DoD Diabetes Guideline Working Group

Dr. Pogach is director, Health Services Research & Development (HSR&D) Center for Healthcare Knowledge Management at the VA New Jersey Health Care System in East Orange and national program director, Endocrinology and Diabetes, Office of Subspecialty Services in the VA Office of Patient Care Services in Washington, DC. Dr. Conlin is chief of medicine at the VA Boston Healthcare System in Massachusetts. Dr. Hobbs is director, Diabetes Care Center, Madigan Healthcare System at Madigan Army Medical Center in Tacoma, Washington. Dr. Vigersky is director, Diabetes Institute, Walter Reed Health Care System at Walter Reed Army Medical Center in Washington, DC. Dr. Aron is associate chief of staff/education and co-director, VA HSR&D Center for Implementation Practice and Research Support at Louis Stokes Cleveland VA Medical Center in Ohio.

Article PDF
Article PDF

Issue
Federal Practitioner - 28(4)
Issue
Federal Practitioner - 28(4)
Page Number
39
Page Number
39
Publications
Publications
Topics
Article Type
Display Headline
Updates in Specialty Care
Display Headline
Updates in Specialty Care
Legacy Keywords
diabetes, clinical practice guidelines, GRADE instrument, comorbid conditions, glycemic targets, A1c tests, estimated average glucose, glucose-based tests, glycemic control, hemolytic anemia, iron deficiency anemia, severe chronic kidney disease, National Glycohemoglobin Standardization Program, coefficient of variation, mean plasma glucose, Working Group, glucose-lowering agents, Action to Control Cardiovascular Risk in Diabetes, VA Diabetes Trial, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluationdiabetes, clinical practice guidelines, GRADE instrument, comorbid conditions, glycemic targets, A1c tests, estimated average glucose, glucose-based tests, glycemic control, hemolytic anemia, iron deficiency anemia, severe chronic kidney disease, National Glycohemoglobin Standardization Program, coefficient of variation, mean plasma glucose, Working Group, glucose-lowering agents, Action to Control Cardiovascular Risk in Diabetes, VA Diabetes Trial, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation
Legacy Keywords
diabetes, clinical practice guidelines, GRADE instrument, comorbid conditions, glycemic targets, A1c tests, estimated average glucose, glucose-based tests, glycemic control, hemolytic anemia, iron deficiency anemia, severe chronic kidney disease, National Glycohemoglobin Standardization Program, coefficient of variation, mean plasma glucose, Working Group, glucose-lowering agents, Action to Control Cardiovascular Risk in Diabetes, VA Diabetes Trial, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluationdiabetes, clinical practice guidelines, GRADE instrument, comorbid conditions, glycemic targets, A1c tests, estimated average glucose, glucose-based tests, glycemic control, hemolytic anemia, iron deficiency anemia, severe chronic kidney disease, National Glycohemoglobin Standardization Program, coefficient of variation, mean plasma glucose, Working Group, glucose-lowering agents, Action to Control Cardiovascular Risk in Diabetes, VA Diabetes Trial, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

BEST PRACTICES IN: Management of Patients With T2DM: The Risk and Role of Chronic Kidney Disease

Article Type
Changed
Fri, 12/07/2018 - 14:12
Display Headline
BEST PRACTICES IN: Management of Patients With T2DM: The Risk and Role of Chronic Kidney Disease

A supplement to Internal Medicine News®. This supplement was sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

 


To view the supplement, click the image above.

Topics

 

  • Epidemiology of CKD/RI With DM
  • Risk Factors for CKD/RI in Patients With T2DM
  • Early Identification and Screening
  • CKD Strongly Effects CV Outcomes in Patients With DM
  • Awareness of the Importance of CKD/RI Is Lacking
  • CKD/RI Increases the Risk for Hypoglycemia in DM Treatment
  • Multifactorial Therapy May Benefit Outcomes in Patients With T2DM and CKD

Faculty/Faculty Disclosure Mark Stolar, MD
Associate Professor of Clinical Medicine
Northwestern University Medical School
Chicago, IL

Michael Kodack, PharmD
Vice President, Medical
BlueSpark Healthcare Communications LLC
Basking Ridge, NJ

Mark Stolar, MD, has served on the Speakers Bureau of Takeda Pharmaceutical Company Limited and has developed educational programs for the TCL Institute and NACE. Michael Kodack, PharmD, is an employee of BlueSpark Healthcare Communications LLC.

Copyright © 2011 Elsevier Inc.

Author and Disclosure Information

 

 

Publications
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

A supplement to Internal Medicine News®. This supplement was sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

 


To view the supplement, click the image above.

Topics

 

  • Epidemiology of CKD/RI With DM
  • Risk Factors for CKD/RI in Patients With T2DM
  • Early Identification and Screening
  • CKD Strongly Effects CV Outcomes in Patients With DM
  • Awareness of the Importance of CKD/RI Is Lacking
  • CKD/RI Increases the Risk for Hypoglycemia in DM Treatment
  • Multifactorial Therapy May Benefit Outcomes in Patients With T2DM and CKD

Faculty/Faculty Disclosure Mark Stolar, MD
Associate Professor of Clinical Medicine
Northwestern University Medical School
Chicago, IL

Michael Kodack, PharmD
Vice President, Medical
BlueSpark Healthcare Communications LLC
Basking Ridge, NJ

Mark Stolar, MD, has served on the Speakers Bureau of Takeda Pharmaceutical Company Limited and has developed educational programs for the TCL Institute and NACE. Michael Kodack, PharmD, is an employee of BlueSpark Healthcare Communications LLC.

Copyright © 2011 Elsevier Inc.

A supplement to Internal Medicine News®. This supplement was sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

 


To view the supplement, click the image above.

Topics

 

  • Epidemiology of CKD/RI With DM
  • Risk Factors for CKD/RI in Patients With T2DM
  • Early Identification and Screening
  • CKD Strongly Effects CV Outcomes in Patients With DM
  • Awareness of the Importance of CKD/RI Is Lacking
  • CKD/RI Increases the Risk for Hypoglycemia in DM Treatment
  • Multifactorial Therapy May Benefit Outcomes in Patients With T2DM and CKD

Faculty/Faculty Disclosure Mark Stolar, MD
Associate Professor of Clinical Medicine
Northwestern University Medical School
Chicago, IL

Michael Kodack, PharmD
Vice President, Medical
BlueSpark Healthcare Communications LLC
Basking Ridge, NJ

Mark Stolar, MD, has served on the Speakers Bureau of Takeda Pharmaceutical Company Limited and has developed educational programs for the TCL Institute and NACE. Michael Kodack, PharmD, is an employee of BlueSpark Healthcare Communications LLC.

Copyright © 2011 Elsevier Inc.

Publications
Publications
Article Type
Display Headline
BEST PRACTICES IN: Management of Patients With T2DM: The Risk and Role of Chronic Kidney Disease
Display Headline
BEST PRACTICES IN: Management of Patients With T2DM: The Risk and Role of Chronic Kidney Disease
Sections
Disallow All Ads

BEST PRACTICES IN: The Treatment of Heavy Menstrual Bleeding

Article Type
Changed
Fri, 12/07/2018 - 09:52
Display Headline
BEST PRACTICES IN: The Treatment of Heavy Menstrual Bleeding


A supplement to Internal Medicine News®. This supplement was sponsored by Ferring Pharmaceuticals.

 


To view the supplement, click the image above.

Topics

 

  • Introduction
  • Definition & Diagnosis
  • Tranexamic Acid for the Treatment of HMB
  • Conclusion

Faculty/Faculty Disclosure

Lee Shulman, MD, FACOG, FACMG
The Anna Ross Lapham Professor in Obstetrics and Gynecology
Feinberg School of Medicine of Northwestern University
Chicago, Illinois

Dr Shulman is a consultant to Ferring Pharmaceuticals, Inc.  

Matt T. Rosenberg, MD
Family Physician
Mid-Michigan Health Centers
Jackson, Michigan

Dr Rosenberg

 

 

 

Copyright © 2011 Elsevier Inc.

Author and Disclosure Information

 

 

Publications
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 


A supplement to Internal Medicine News®. This supplement was sponsored by Ferring Pharmaceuticals.

 


To view the supplement, click the image above.

Topics

 

  • Introduction
  • Definition & Diagnosis
  • Tranexamic Acid for the Treatment of HMB
  • Conclusion

Faculty/Faculty Disclosure

Lee Shulman, MD, FACOG, FACMG
The Anna Ross Lapham Professor in Obstetrics and Gynecology
Feinberg School of Medicine of Northwestern University
Chicago, Illinois

Dr Shulman is a consultant to Ferring Pharmaceuticals, Inc.  

Matt T. Rosenberg, MD
Family Physician
Mid-Michigan Health Centers
Jackson, Michigan

Dr Rosenberg

 

 

 

Copyright © 2011 Elsevier Inc.


A supplement to Internal Medicine News®. This supplement was sponsored by Ferring Pharmaceuticals.

 


To view the supplement, click the image above.

Topics

 

  • Introduction
  • Definition & Diagnosis
  • Tranexamic Acid for the Treatment of HMB
  • Conclusion

Faculty/Faculty Disclosure

Lee Shulman, MD, FACOG, FACMG
The Anna Ross Lapham Professor in Obstetrics and Gynecology
Feinberg School of Medicine of Northwestern University
Chicago, Illinois

Dr Shulman is a consultant to Ferring Pharmaceuticals, Inc.  

Matt T. Rosenberg, MD
Family Physician
Mid-Michigan Health Centers
Jackson, Michigan

Dr Rosenberg

 

 

 

Copyright © 2011 Elsevier Inc.

Publications
Publications
Article Type
Display Headline
BEST PRACTICES IN: The Treatment of Heavy Menstrual Bleeding
Display Headline
BEST PRACTICES IN: The Treatment of Heavy Menstrual Bleeding
Sections
Disallow All Ads